Guha, S., Ibrahim, A., Geng, P., Wu, Q., Chou, Y., Akin, O., Schwartz, L. H., Xie, C.-M., & Zhao, B. (2025). Variability of HCC Tumor Diameter and Density Measurements on Dynamic Contrast-Enhanced Computed Tomography. Tomography, 11(3), 36. https://doi.org/10.3390/tomography11030036

Rosenthal, B. E., Hoteit, M. A., Lluri, G., Haeffele, C., Daugherty, T., Krasuski, R. A., Serfas, J. D., de Freitas, R. A., Porlier, A., Lubert, A. M., Wu, F. M., Valente, A. M., Krieger, E. V., Buber, Y., Rodriguez, F. H., Gaignard, S., Saraf, A., Hindes, M., Earing, M. G., … Kim, Y. Y. (2025). Characteristics and Survival Outcomes of Hepatocellular Carcinoma After the Fontan Operation. JACC: Advances, 4(4), 101646. https://doi.org/10.1016/j.jacadv.2025.101646

Adamo, R. G., Lam, E., Salameh, J.-P., van der Pol, C. B., Goins, S. M., Dawit, H., Costa, A. F., Levis, B., Singal, A. G., Chernyak, V., Sirlin, C. B., Bashir, M. R., Tang, A., Alhasan, A., Allen, B. C., Reiner, C. S., Clarke, C., Ludwig, D. R., Cerny, M., … McInnes, M. D. F. (2024). Do Risk Factors for HCC Impact the Association of CT/MRI LIRADS Major Features With HCC? An Individual Participant Data Meta-Analysis. Canadian Association of Radiologists Journal. https://doi.org/10.1177/08465371241306297

Ibrahim, A., Guha, S., Lu, L., Geng, P., Wu, Q., Chou, Y., Yang, H., Wang, D., Schwartz, L. H., Xie, C., & Zhao, B. (2024). The reproducibility and predictivity of radiomic features extracted from dynamic contrast-enhanced computed tomography of hepatocellular carcinoma. PLOS ONE, 19(9), e0310486. https://doi.org/10.1371/journal.pone.0310486

Abou-Alfa, G. K., Geyer, S. M., Nixon, A. B., Innocenti, F., Shi, Q., Kumthekar, P., Jacobson, S., El Dika, I., Yaqubie, A., Lopez, J., Huang, B., Tang, Y.-W., Wen, Y., Schwartz, L. H., El-Khoueiry, A. B., Knox, J. J., Rajdev, L., Bertagnolli, M. M., Meyerhardt, J. A., … Venook, A. P. (2024). CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer Research Communications, 4(3), 682–690. https://doi.org/10.1158/2767-9764.crc-22-0516

Phipps, M. M., Choi, A. J., & Brown Jr, R. S. (2024). Narrative review of management of cirrhosis during the treatment of hepatocellular carcinoma. Annals of Palliative Medicine, 13(1), 141–149. https://doi.org/10.21037/apm-23-173

Blusztein, D., Hahn, R. T., Rivas, C. G., Tomlinson, S., Leb, J. S., George, I., & Kodali, S. K. (2023). THE EFFECT OF MEDICAL THERAPY ON TRICUSPID VALVE ANATOMY IN THE EVALUATION OF TRANSCATHETER TREATMENT OF TRICUSPID REGURGITATION. Journal of the American College of Cardiology, 81(8), 889. https://doi.org/10.1016/s0735-1097(23)01333-5

Tabrizian, P., Holzner, M. L., Mehta, N., Halazun, K., Agopian, V. G., Yao, F., Busuttil, R. W., Roberts, J., Emond, J. C., Samstein, B., Brown, R. S., Najjar, M., Chapman, W. C., Doyle, M. Mb., Florman, S. S., Schwartz, M. E., & Llovet, J. M. (2022). Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma. JAMA Surgery. https://doi.org/10.1001/jamasurg.2022.2800